How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

26,588 results for

Obesity Medication

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

26461. Complex interactions in complex traits: obesity and asthma (PubMed)

Complex interactions in complex traits: obesity and asthma 11514709 2001 10 04 2018 11 13 0040-6376 56 Suppl 2 2001 Sep Thorax Thorax Complex interactions in complex traits: obesity and asthma. ii64-73 Tantisira K G KG Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Weiss S T ST eng 2T32 HL07427-21 HL NHLBI NIH HHS United States R01 HL66795 HL NHLBI NIH HHS United States Journal Article Research Support, U.S. Gov't, P.H.S. Review England Thorax (...) 0417353 0040-6376 IM Asthma etiology genetics Humans Obesity complications genetics Risk Factors Weight Loss physiology 225 2001 8 22 10 0 2001 10 5 10 1 2001 8 22 10 0 ppublish 11514709 PMC1765987 Hum Biol. 1987 Dec;59(6):921-31 3443443 Thorax. 1994 Sep;49(9):875-80 7940426 J Perinat Med. 2000;28(6):428-31 11155426 Am J Respir Crit Care Med. 1997 Dec;156(6):1752-9 9412551 Ann Epidemiol. 1999 Oct;9(7):424-35 10501410 Afr J Med Med Sci. 1985 Sep-Dec;14(3-4):115-20 3004170 Thorax. 1999 Sep;54(9):757-61

Full Text available with Trip Pro

2001 Thorax

26462. Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias (PubMed)

Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias 12041851 2002 06 21 2018 11 13 0820-3946 166 10 2002 May 14 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias. 1307-8 Wooltorton Eric E eng Journal Article Canada CMAJ 9711805 0820-3946 0 Appetite Depressants 0 Cyclobutanes WV5EC51866 sibutramine AIM IM Appetite Depressants adverse effects therapeutic use (...) Arrhythmias, Cardiac chemically induced Cyclobutanes adverse effects therapeutic use Humans Hypertension chemically induced Obesity drug therapy 2002 6 4 10 0 2002 6 22 10 1 2002 6 4 10 0 ppublish 12041851 PMC111085 Lancet. 2000 Dec 23-30;356(9248):2119-25 11191537 Arch Intern Med. 2000 Jul 24;160(14):2185-91 10904462 Int J Obes Relat Metab Disord. 2000 Feb;24(2):144-50 10702763 Diabetes Obes Metab. 2000 Jun;2(3):175-87 11220553 Obes Res. 1999 Jul;7(4):363-9 10440592 JAMA. 2001 Sep 19;286(11):1331-9

Full Text available with Trip Pro

2002 CMAJ: Canadian Medical Association Journal

26463. The Canadian obesity epidemic, 1985–1998 (PubMed)

The Canadian obesity epidemic, 1985–1998 12002980 2002 05 28 2018 11 13 0820-3946 166 8 2002 Apr 16 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ The Canadian obesity epidemic, 1985-1998. 1039-40 Katzmarzyk Peter T PT School of Kinesiology and Health Science, York University, Toronto, Ont. katzmarz@yorku.ca eng Journal Article Canada CMAJ 9711805 0820-3946 AIM IM Adult Body Mass Index Canada epidemiology Disease Outbreaks Humans Obesity

Full Text available with Trip Pro

2002 CMAJ: Canadian Medical Association Journal

26464. Obesity, gender, and colon cancer (PubMed)

Obesity, gender, and colon cancer 12117867 2002 09 10 2018 11 13 0017-5749 51 2 2002 Aug Gut Gut Obesity, gender, and colon cancer. 147 Giovannucci E E Harvard Medical School, Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA. edward.giovannucci@channing.harvard.edu eng Comment Journal Article England Gut 2985108R 0017-5749 0 Estrogens 0 Insulin 67763-96-6 Insulin-Like Growth Factor I AIM IM Gut. 2002 Aug;51(2):191-4 12117878 Adult Colonic Neoplasms blood etiology Estrogens blood (...) Female Humans Insulin blood Insulin-Like Growth Factor I metabolism Male Menopause physiology Middle Aged Obesity blood complications Risk Factors Sex 2002 7 16 10 0 2002 9 11 10 1 2002 7 16 10 0 ppublish 12117867 PMC1773303 Maturitas. 2001 Aug 25;39(2):97-115 11514109 Semin Reprod Endocrinol. 1999;17(4):349-58 10851574 Br J Cancer. 2001 Aug 3;85(3):346-9 11487263 Proc Soc Exp Biol Med. 1993 Oct;204(1):4-29 7690486 J Nutr. 2001 Nov;131(11 Suppl):3109S-20S 11694656 Gut. 2002 Aug;51(2):191-4 12117878 J

Full Text available with Trip Pro

2002 Gut

26465. Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity (PubMed)

Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity 11581296 2001 12 04 2018 11 13 0021-9738 108 7 2001 Oct The Journal of clinical investigation J. Clin. Invest. Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity. 963-4 Schwartz M W MW Division of Metabolism, Endocrinology and Nutrition, University of Washington, Harborview Medical Center, Seattle, Washington 98104-2499, USA. mschwart@u.washington.edu eng Comment Journal Article (...) Review United States J Clin Invest 7802877 0021-9738 0 Receptor, Melanocortin, Type 3 0 Receptor, Melanocortin, Type 4 0 Receptors, Corticotropin IY9XDZ35W2 Glucose AIM IM J Clin Invest. 2001 Oct;108(7):1079-85 11581309 Animals Central Nervous System metabolism physiology Diabetes Mellitus, Type 2 metabolism physiopathology Energy Metabolism Glucose metabolism Homeostasis Humans Neurons metabolism physiology Neurosecretory Systems metabolism physiology Obesity metabolism physiopathology Receptor

Full Text available with Trip Pro

2001 Journal of Clinical Investigation

26466. Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction. (PubMed)

Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction. 6775739 1981 01 29 2018 11 30 0007-1447 281 6236 1980 Aug 02 British medical journal Br Med J Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction. 358-9 Kopelman P G PG Pilkington T R TR Jeffcoate S L SL White N N eng Journal Article England Br Med J 0372673 0007-1447 0 Insulin 5Y5F15120W Thyrotropin-Releasing Hormone 9002 (...) -62-4 Prolactin 9002-72-6 Growth Hormone WI4X0X7BPJ Hydrocortisone AIM IM Female Growth Hormone metabolism Humans Hydrocortisone metabolism Hypoglycemia physiopathology Hypothalamus physiopathology Insulin Obesity physiopathology therapy Prolactin metabolism Thyrotropin-Releasing Hormone 1980 8 2 1980 8 2 0 1 1980 8 2 0 0 ppublish 6775739 PMC1713528 Endocrinology. 1976 Jan;98(1):139-45 942910 Lancet. 1979 Apr 7;1(8119):747-50 85990 Physiol Rev. 1979 Jul;59(3):719-809 379887 Br Med J. 1980 Jan

Full Text available with Trip Pro

1980 British medical journal

26467. Management of weight problems and obesity: knowledge, attitudes and current practice of general practitioners. (PubMed)

effective than the media or the family in persuading overweight patients to lose weight. Doctors said they were prepared to counsel on weight reduction but felt they had little success in achieving weight loss in patients. Experience was ranked as the most important contributor to knowledge about managing obesity, and medical school was rated as least important. Further study is needed to discover how different practices and attitudes affect patient management and which ones are associated with greatest (...) Management of weight problems and obesity: knowledge, attitudes and current practice of general practitioners. A postal questionnaire was used to assess general practitioners' knowledge, attitudes and current practice of treatment regarding obesity and weight problems. Overall, 299 responses (75%) were received from general practitioners randomly selected from family practitioner committee lists in Portsmouth and Norwich. Currently 27% of the doctors were overweight and a further 3% obese. Many

Full Text available with Trip Pro

1991 The British Journal of General Practice

26468. Adolescent nutrition: 3. Obesity. Nutrition Committee, Canadian Paediatric Society. (PubMed)

Adolescent nutrition: 3. Obesity. Nutrition Committee, Canadian Paediatric Society. 6883254 1983 10 21 2018 11 13 0008-4409 129 6 1983 Sep 15 Canadian Medical Association journal Can Med Assoc J Adolescent nutrition: 3. Obesity. Nutrition Committee, Canadian Paediatric Society. 549-51 eng Journal Article Canada Can Med Assoc J 0414110 0008-4409 AIM IM Adolescent Adult Age Factors Child Humans Infant Obesity epidemiology etiology therapy 1983 9 15 1983 9 15 0 1 1983 9 15 0 0 ppublish 6883254

Full Text available with Trip Pro

1983 Canadian Medical Association Journal

26469. Human chorionic gonadotropin is of no value in the management of obesity. (PubMed)

Human chorionic gonadotropin is of no value in the management of obesity. 6340811 1983 06 17 2018 11 13 0008-4409 128 10 1983 May 15 Canadian Medical Association journal Can Med Assoc J Human chorionic gonadotropin is of no value in the management of obesity. 1156-7 Birmingham C L CL Smith K C KC eng Clinical Trial Journal Article Canada Can Med Assoc J 0414110 0008-4409 0 Chorionic Gonadotropin AIM IM Chorionic Gonadotropin adverse effects therapeutic use Clinical Trials as Topic Double-Blind (...) Method Humans Obesity drug therapy 1983 5 15 1983 5 15 0 1 1983 5 15 0 0 ppublish 6340811 PMC1875285 Am J Obstet Gynecol. 1972 Apr 15;112(8):1052-60 5017635 Am J Clin Nutr. 1964 Sep;15:188-90 14212755 Am J Clin Nutr. 1973 Oct;26(10):1039-41 4754660 Am J Clin Nutr. 1974 May;27(5):450-5 4596027 Am J Obstet Gynecol. 1974 Nov 15;120(6):855 4429101 J Reprod Med. 1974 Mar;12(3):117-20 4449102 N Engl J Med. 1975 Apr 17;292(16):871 1113825 Am J Clin Nutr. 1976 Sep;29(9):940-8 786001 JAMA. 1976 Nov 29;236(22

Full Text available with Trip Pro

1983 Canadian Medical Association Journal

26470. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. (PubMed)

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. Hypertension and glucose intolerance, determined in a random population sample (n = 2,475), showed a highly significant (P less than 0.001) association from the mildest levels of both conditions, independent of the confounding effects of age, sex, obesity, and antihypertensive medications. Summary rate ratios for hypertension were 1.48 (1.18-1.87) in abnormal tolerance and 2.26 (1.69-2.84) in diabetes compared (...) with normal tolerance. Altogether, 83.4% of the hypertensives were either glucose-intolerant or obese--both established insulin-resistant conditions. Fasting and post-load insulin levels in a representative subgroup (n = 1,241) were significantly elevated in hypertension independent of obesity, glucose intolerance, age, and antihypertensive medications. The mean increment in summed 1- and 2-h insulin levels (milliunits per liter) compared with nonobese normotensives with normal tolerance was 12

Full Text available with Trip Pro

1985 Journal of Clinical Investigation

26471. The menace of obesity. 1926. (PubMed)

The menace of obesity. 1926. 1742698 1992 01 13 2016 11 23 0820-3946 145 12 1991 Dec 15 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ The menace of obesity. 1926. 1597 eng Biography Classical Article Historical Article Journal Article Canada CMAJ 9711805 0820-3946 AIM IM Q History, 20th Century Humans Obesity history United Kingdom Thompson V V 1991 12 15 1991 12 15 0 1 1991 12 15 0 0 ppublish 1742698 PMC1336081

Full Text available with Trip Pro

1991 CMAJ: Canadian Medical Association Journal

26472. Obesity and coronary heart disease. (PubMed)

Obesity and coronary heart disease. 1737317 1992 03 19 2018 11 13 0820-3946 146 4 1992 Feb 15 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ Obesity and coronary heart disease. 525 Roncari D A DA University of Toronto, ON. eng Journal Article Canada CMAJ 9711805 0820-3946 AIM IM Abdomen Coronary Disease epidemiology etiology Humans Obesity complications Risk Factors 1992 2 15 1992 2 15 0 1 1992 2 15 0 0 ppublish 1737317 PMC1488454 Am J Clin Nutr

Full Text available with Trip Pro

1992 CMAJ: Canadian Medical Association Journal

26473. Obesity. Part II--Treatment. (PubMed)

Obesity. Part II--Treatment. Conventional diets and increased exercise are the cornerstones of traditional therapy for obesity, but available data suggest that the most important component of any program is the associated behavior modification through which new ways of dealing with old problems can be learned and continually applied. This combined with very-low-calorie diets--less than 800 kcal per day--are in wide use, mostly under medical supervision. The currently available appetite (...) -suppressing drugs are of limited efficacy, but many new ones are under active development and hold promise for the future. The most effective surgical intervention appears to be the gastric bypass operation, but this should be reserved for those who are at high risk from their obesity.

Full Text available with Trip Pro

1988 Western Journal of Medicine

26474. Obesity and abnormal behaviour associated with interstitial deletion of chromosome 18 (q12.2q21.1). (PubMed)

Obesity and abnormal behaviour associated with interstitial deletion of chromosome 18 (q12.2q21.1). 2918529 1989 04 06 2018 11 13 0022-2593 26 1 1989 Jan Journal of medical genetics J. Med. Genet. Obesity and abnormal behaviour associated with interstitial deletion of chromosome 18 (q12.2q21.1). 62-3 Wilson G N GN Department of Pediatrics, William Beaumont Hospital, Royal Oak, Michigan 48072-2735. Al Saadi A A AA eng Case Reports Journal Article England J Med Genet 2985087R 0022-2593 IM (...) Autistic Disorder genetics Child Child Behavior Disorders genetics Chromosome Deletion Chromosomes, Human, Pair 18 Humans Karyotyping Male Obesity genetics 1989 1 1 1989 1 1 0 1 1989 1 1 0 0 ppublish 2918529 PMC1015541 J Med Genet. 1974 Dec;11(4):353-66 4140909 Nature. 1987 Aug 13-19;328(6131):614-6 3039373 Am J Med Genet. 1979;3(2):155-74 474629

Full Text available with Trip Pro

1989 Journal of Medical Genetics

26475. Physiologic approaches to the control of obesity. (PubMed)

Physiologic approaches to the control of obesity. Morbid obesity is a major health problem in this country and throughout the world. In addition to its social stigma (in the western world), obesity exacerbates several disease states such as diabetes, hypertension, cardiac disease and restrictive lung disease. When effective medical treatment of obesity becomes available, it will depend in part upon understanding the physiologic factors that control satiety. This review summarizes (...) the information available on brain and gut control mechanisms of satiety. Brain nuclei located in the lateral hypothalamus, ventromedial hypothalamus, and other paraventricular areas are the sites of action for potent neuropeptides, such as cholecystokinin (CCK) and neuropeptide Y, that appear to regulate feeding. Exogenous CCK has been used clinically to decrease meal size in obese patients. The sites of the satiety cascade that are most often manipulated are the gastric and intestinal phases. Physiologic

Full Text available with Trip Pro

1989 Annals of Surgery

26476. Obesity. (PubMed)

in the face of famine. These include changes in water balance, metabolic rate, and appetite. Metabolic rate declines, allowing the individual to burn fewer and fewer calories. Each time a woman diets she tends to lose weight less rapidly than the time before. "Restrained eating" predisposes binge eating. Indeed, bulimia rarely occurs in the absence of prior caloric restrictions. Current medical definitions of obesity do not consider these nuances. Existing definitions "over-diagnose" obesity in women (...) Obesity. Obesity is not a single disease, but a variety of conditions resulting from different mechanisms and associated with various types and degrees of risks. To determine who should lose weight, how much weight should be lost, and how to undertake weight loss, the following types of information are needed: personal-demographic data, developmental patterns, family history, energy balance, body composition/fat distribution, psychological/behavioral measures, endocrine/metabolic measures

Full Text available with Trip Pro

1987 Public Health Reports

26477. Massive necrosis of fat and skin as complication of obesity. (PubMed)

Massive necrosis of fat and skin as complication of obesity. 2920339 1989 04 18 2018 11 13 0820-3946 140 6 1989 Mar 15 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ Massive necrosis of fat and skin as complication of obesity. 665-8 Janigan D T DT Department of Pathology, Victoria General Hospital, Halifax. Prokopetz R D RD Chawla S S Durning R G RG eng Journal Article Canada CMAJ 9711805 0820-3946 0 Phosphates AIM IM Adipose Tissue blood supply (...) pathology Adult Arteries pathology Calcinosis blood etiology pathology Female Humans Middle Aged Necrosis Obesity blood complications pathology Obesity, Morbid blood complications pathology Phosphates blood Skin Ulcer blood etiology pathology 1989 3 15 1989 3 15 0 1 1989 3 15 0 0 ppublish 2920339 PMC1268756 Ann Intern Med. 1969 Jul;71(1):129-38 4892965 JAMA. 1974 Jul 22;229(4):419-24 4275980 Am J Med. 1956 Oct;21(4):583-95 13362289 Lancet. 1968 Aug 10;2(7563):323-5 4173738 Br J Dermatol. 1983 Jul;109(1

Full Text available with Trip Pro

1989 CMAJ: Canadian Medical Association Journal

26478. Does Presenting Patients BMI Increase Documentation of Obesity? (PubMed)

Does Presenting Patients BMI Increase Documentation of Obesity? Despite the associated health consequences, obesity is infrequently documented as a problem in medical charts. The purpose of this study is to determine whether a simple intervention (routine listing of the BMI on the medical chart) will increase physician documentation of obesity in the medical record.Participants were resident physicians in a family medicine residency program. Participants were randomly assigned to either (...) an experimental group or a control group. For experimental group physicians, the Body Mass Index was listed alongside other vital signs of patients seen in an ambulatory setting. Physician documentation of patient obesity was assessed by chart review after patient visits. Documentation was defined as inclusion of obesity on the problem list or in the progress note.The intervention did not significantly increase the rate of documentation of obesity in the medical chart. Several reasons for the lack of change

Full Text available with Trip Pro

2002 Medical education online Controlled trial quality: uncertain

26479. A double-blind study of diethylpropion in obesity. (PubMed)

A double-blind study of diethylpropion in obesity. 13743380 1998 11 01 2018 11 30 0002-9629 242 1961 Aug The American journal of the medical sciences Am. J. Med. Sci. A double-blind study of diethylpropion in obesity. 201-6 ROSENBERG B A BA eng Journal Article United States Am J Med Sci 0370506 0002-9629 0 Propiophenones 0 Sympathomimetics Q94YYU22B8 Diethylpropion OM Diethylpropion Double-Blind Method Obesity therapy Propiophenones therapy Sympathomimetics therapy OBESITY/therapy

1998 The American journal of the medical sciences Controlled trial quality: uncertain

26480. Diethylpropion in the treatment of obesity. A cross-over trial of a long-acting preparation. (PubMed)

Diethylpropion in the treatment of obesity. A cross-over trial of a long-acting preparation. 13903442 1998 11 01 2018 12 01 0041-6193 30 1961 Dec 01 The Ulster medical journal Ulster Med J Diethylpropion in the treatment of obesity. A cross-over trial of a long-acting preparation. 109-13 HADDEN D R DR LUCEY C C eng Journal Article Northern Ireland Ulster Med J 0417367 0041-6193 0 Propiophenones 0 Sympathomimetics Q94YYU22B8 Diethylpropion OM Diethylpropion Humans Obesity Propiophenones therapy

1998 The Ulster medical journal Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>